FDA.reportPublic FDA data

Ceftazidime

Product NDC
44567-237
11-digit product format
445670237
Labeler code
44567
Product ID
44567-237_a225696b-a8e8-45cc-a329-9f312e03ea1a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ceftazidime
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Labeler
WG Critical Care, LLC
Application
ANDA062640
Marketing category
ANDA
Marketing start
2013-01-31
Substance
CEFTAZIDIME
Active strength
6 g/100mL
Pharmacologic classes
Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Ceftazidime
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CEFTAZIDIME6 g/100mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii9M416Z9QNR
Rxcui242800

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fb7d24f2-fcd1-4dc6-b9d0-b1f65bfffab5Product name120150409

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
44567-237-06Ceftazidime6 in 1 CARTONINJECTION, POWDER, FOR SOLUTION68
44567-237-06Ceftazidime100 mL in 1 VIALINJECTION, POWDER, FOR SOLUTION1008

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
44567-237-06EA - Each44567-237b12823cc-4f24-47e8-ba39-bb59f807e8a912013-08-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CEFTAZIDIMEACTIVE INGREDIENT9M416Z9QNRCEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [WG CRITICAL CARE, LLC]2
CEFTAZIDIME ANHYDROUSACTIVE MOIETYDZR1ENT301CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [WG CRITICAL CARE, LLC]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
44567-237CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [WG CRITICAL CARE, LLC]8Current NDC, Legacy NDC, 2 package rows20210924_22d6534c-4488-48a1-8d78-e2fb908259de.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
242800cefTAZidime 200 MG/ML Injectable SolutionPSN22d6534c-4488-48a1-8d78-e2fb908259de8
242800ceftazidime 200 MG/ML Injectable SolutionSCD22d6534c-4488-48a1-8d78-e2fb908259de8
242800ceftazidime 200 MG/ML Concentrate for Injectable SolutionSY22d6534c-4488-48a1-8d78-e2fb908259de8
242800ceftazidime 6 GM per 30 ML Injectable SolutionSY22d6534c-4488-48a1-8d78-e2fb908259de8

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
44567-237-06445670237066 VIAL in 1 CARTON (44567-237-06) / 100 mL in 1 VIAL6 vial2013-01-310000-00-00NoNoCurrent